SS
Sobaran Singh
About Sobaran Singh
Data last updated:
Sobaran Singh is a Director at Octavus Consulting Private Limited (since 2017) and Director at Pharmashots Media Private Limited (since 2023). The companies operate in Information Technology and Media and Publishing. The 2 current companies with reported revenue have a combined latest revenue of ₹2.35 Cr; the largest is Octavus Consulting Private Limited at ₹2.18 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jul 2017 | 2017 | ₹2.18 Cr (FY 2024) | Active | |
| Director | 10 Mar 2023 | 2023 | ₹17.6 Lakh (FY 2025) | Active |
Board colleagues of Sobaran Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manvi Choudhary | 10870093 | Octavus Consulting Private Limited | Additional Director |
| Reeta Sehgal | 07893861 | Pharmashots Media Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sobaran Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sobaran Singh
Sobaran Singh currently holds 2 directorships: Octavus Consulting Private Limited (Director, since 31 Jul 2017, revenue ₹2.18 Cr (FY 2024)); Pharmashots Media Private Limited (Director, since 10 Mar 2023, revenue ₹17.6 Lakh (FY 2025)).
Sobaran Singh was first appointed on 31 Jul 2017 as Director at Octavus Consulting Private Limited. The most recent appointment on record is 10 Mar 2023 at Pharmashots Media Private Limited.
The 2 current companies of Sobaran Singh that report revenue have a combined latest revenue of ₹2.35 Cr: Octavus Consulting Private Limited ₹2.18 Cr (FY 2024); Pharmashots Media Private Limited ₹17.6 Lakh (FY 2025).
The current boards of Sobaran Singh's companies include Manvi Choudhary (Octavus Consulting Private Limited), Reeta Sehgal (Pharmashots Media Private Limited).